NASDAQ: DWTX
Dogwood Therapeutics Inc Stock Ownership - Who owns Dogwood Therapeutics?

Insider buying vs selling

Have Dogwood Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when DWTX insiders and whales buy or sell their stock.

DWTX Shareholders

What type of owners hold Dogwood Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
William Pridgen41.94%801,489$3.94MInsider
Sealbond Ltd11.06%211,383$1.04MInsider
Richard Alan Burch7.73%147,681$726.59kInsider
Gregory Scott Duncan3.01%57,461$282.71kInsider
Geode Capital Management LLC0.67%12,823$63.09kInstitution
David R. Keefer0.67%12,808$63.02kInsider
Vanguard Group Inc0.62%11,782$57.97kInstitution
La Rosa Abel De0.21%4,000$19.68kInsider
Angela Walsh0.16%3,000$14.76kInsider
John C. Thomas0.05%1,000$4.92kInsider

1 of 2

DWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DWTX1.30%64.86%
SNSE0.16%99.84%Net Selling
RNAZ0.01%99.99%
SNGX0.14%99.86%
EVGN0.51%0.00%

Dogwood Therapeutics Stock Ownership FAQ

Who owns Dogwood Therapeutics?

Dogwood Therapeutics (NASDAQ: DWTX) is owned by 1.30% institutional shareholders, 64.86% Dogwood Therapeutics insiders, and 33.84% retail investors. William Pridgen is the largest individual Dogwood Therapeutics shareholder, owning 801,489.00 shares representing 41.94% of the company. William Pridgen's Dogwood Therapeutics shares are currently valued at $3.94M.

If you're new to stock investing, here's how to buy Dogwood Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.